217 related articles for article (PubMed ID: 17328071)
1. Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system.
Katzav A; Solodeev I; Brodsky O; Chapman J; Pick CG; Blank M; Zhang W; Reichlin M; Shoenfeld Y
Arthritis Rheum; 2007 Mar; 56(3):938-48. PubMed ID: 17328071
[TBL] [Abstract][Full Text] [Related]
2. Anti-P ribosomal antibodies induce defect in smell capability in a model of CNS -SLE (depression).
Katzav A; Ben-Ziv T; Chapman J; Blank M; Reichlin M; Shoenfeld Y
J Autoimmun; 2008 Dec; 31(4):393-8. PubMed ID: 18947972
[TBL] [Abstract][Full Text] [Related]
3. To smell autoimmunity: anti-P-ribosomal autoantibodies, depression, and the olfactory system.
Shoenfeld Y
J Autoimmun; 2007; 28(2-3):165-9. PubMed ID: 17382516
[TBL] [Abstract][Full Text] [Related]
4. A murine monoclonal anti-idiotype to anti-ribosomal P antibodies: production, characterization, and use in systemic lupus erythematosus.
Pan ZJ; Anderson CJ; Stafford HA
Clin Immunol; 2001 Sep; 100(3):289-97. PubMed ID: 11513542
[TBL] [Abstract][Full Text] [Related]
5. Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus.
Isshi K; Hirohata S
Arthritis Rheum; 1998 Oct; 41(10):1819-27. PubMed ID: 9778223
[TBL] [Abstract][Full Text] [Related]
6. Anti-ribosomal P protein antibody in human systemic lupus erythematosus up-regulates the expression of proinflammatory cytokines by human peripheral blood monocytes.
Nagai T; Arinuma Y; Yanagida T; Yamamoto K; Hirohata S
Arthritis Rheum; 2005 Mar; 52(3):847-55. PubMed ID: 15751081
[TBL] [Abstract][Full Text] [Related]
7. Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus.
Hirohata S; Arinuma Y; Takayama M; Yoshio T
Arthritis Res Ther; 2007; 9(3):R44. PubMed ID: 17472755
[TBL] [Abstract][Full Text] [Related]
8. Intrathecal antibodies and brain damage in autoimmune MRL mice.
Stanojcic M; Loheswaran G; Xu L; Hoffman SA; Sakic B
Brain Behav Immun; 2010 Feb; 24(2):289-97. PubMed ID: 19853033
[TBL] [Abstract][Full Text] [Related]
9. A close temporal relationship of liver disease to antiribosomal P0 protein antibodies and central nervous system disease in patients with systemic lupus erythematosus.
Yoshio T; Masuyama JI; Minota S; Kaneko N; Iwamoto M; Okazaki H; Mimori A; Takeda A; Kano S
J Rheumatol; 1998 Apr; 25(4):681-8. PubMed ID: 9558169
[TBL] [Abstract][Full Text] [Related]
10. Effect of Withania somnifera on forced swimming test induced immobility in mice and its interaction with various drugs.
Shah PC; Trivedi NA; Bhatt JD; Hemavathi KG
Indian J Physiol Pharmacol; 2006; 50(4):409-15. PubMed ID: 17402272
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of depressive and anxiety disorders in systemic lupus erythematosus and their association with anti-ribosomal P antibodies.
Nery FG; Borba EF; Viana VS; Hatch JP; Soares JC; Bonfá E; Neto FL
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):695-700. PubMed ID: 18077068
[TBL] [Abstract][Full Text] [Related]
12. Production and characterization of a human monoclonal anti-idiotype to anti-ribosomal P antibodies.
Zhang W; Reichlin M
Clin Immunol; 2005 Feb; 114(2):130-6. PubMed ID: 15639646
[TBL] [Abstract][Full Text] [Related]
13. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
[TBL] [Abstract][Full Text] [Related]
14. Clinical and diagnostic value of ribosomal P autoantibodies in systemic lupus erythematosus.
Haddouk S; Marzouk S; Jallouli M; Fourati H; Frigui M; Hmida YB; Koubaa F; Sellami W; Baklouti S; Hachicha J; Bahloul Z; Masmoudi H
Rheumatology (Oxford); 2009 Aug; 48(8):953-7. PubMed ID: 19502474
[TBL] [Abstract][Full Text] [Related]
15. Anti-ribosomal-P antibodies in lupus patients and healthy controls: evaluation of three ELISA assays.
Agmon-Levin N; Gilburd B; Kivity S; Katz BS; Flitman-Katzevman I; Shoenfeld N; Paran D; Langevitz P; Shoenfeld Y
Isr Med Assoc J; 2009 Jul; 11(7):403-6. PubMed ID: 19911490
[TBL] [Abstract][Full Text] [Related]
16. Antibody-specific behavioral effects: intracerebroventricular injection of antiphospholipid antibodies induces hyperactive behavior while anti-ribosomal-P antibodies induces depression and smell deficits in mice.
Katzav A; Ben-Ziv T; Blank M; Pick CG; Shoenfeld Y; Chapman J
J Neuroimmunol; 2014 Jul; 272(1-2):10-5. PubMed ID: 24837568
[TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase 10A inhibition is associated with locomotor and cognitive deficits and increased anxiety in mice.
Hebb AL; Robertson HA; Denovan-Wright EM
Eur Neuropsychopharmacol; 2008 May; 18(5):339-63. PubMed ID: 17913473
[TBL] [Abstract][Full Text] [Related]
18. Cellular dysfunction induced by penetration of autoantibodies into living cells: cellular damage and dysfunction mediated by antibodies to dsDNA and ribosomal P proteins.
Reichlin M
J Autoimmun; 1998 Oct; 11(5):557-61. PubMed ID: 9802943
[TBL] [Abstract][Full Text] [Related]
19. Effects of sustained i.c.v. infusion of lupus CSF and autoantibodies on behavioral phenotype and neuronal calcium signaling.
Kapadia M; Bijelić D; Zhao H; Ma D; Stojanovich L; Milošević M; Andjus P; Šakić B
Acta Neuropathol Commun; 2017 Sep; 5(1):70. PubMed ID: 28882191
[TBL] [Abstract][Full Text] [Related]
20. Association of anti-acidic ribosomal protein P0 and anti-galectin 3 antibodies with the development of skin lesions in systemic lupus erythematosus.
Shi ZR; Tan GZ; Meng Z; Yu M; Li KW; Yin J; Wei KH; Luo YJ; Jia SQ; Zhang SJ; Wu J; Mi XB; Wang L
Arthritis Rheumatol; 2015 Jan; 67(1):193-203. PubMed ID: 25307291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
